Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 14/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14840328 | 0.94 | FDPS (0.48) | FDPSSMPD1GGPS1ESR1ESR2 | |
| SCHEMBL7011302 | 0.92 | FDPS (0.46) | FDPSSMPD1GGPS1 | |
| SCHEMBL7719887 | 0.90 | FDPS (0.48) | FDPSSMPD1GGPS1 | |
| SCHEMBL999922 | 0.89 | FDPS (0.48) | FDPSSMPD1GGPS1 | |
| SCHEMBL14840392 | 0.88 | — | — | |
| SCHEMBL22915512 | 0.84 | FDPS (0.41) | FDPSSMPD1GGPS1 | |
| SCHEMBL6151052 | 0.83 | — | — | |
| SCHEMBL1271337 | 0.83 | FDPS (0.52) | FDPSSMPD1GGPS1 | |
| SCHEMBL5391830 | 0.83 | FDPS (0.52) | FDPSSMPD1GGPS1 | |
| SCHEMBL28766865 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7585850-B2 | Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases | ADENOBIO N.V. (NL) | 2009-09-08 | — | — | US | disclosed |
| WO-2005074946-A1 | STABLE AND ACTIVE COMPLEXES OF ADENOSINE AND ADENOSINE PHOSPHATES WITH AMINOALCOHOLS FOR THE TREATMENT OF PULMONARY ARTERY HYPERTENSION, CARDIAC FAILURE AND OTHER DISEASES | ADENOBIO N.V. (NL) | 2005-08-18 | — | — | WO | disclosed |
| US-20050176675-A1 | Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases | ADENOBIO N.V. (NL) | 2005-08-11 | — | — | US | disclosed |
| US-4868259-A | Emulsion polymerization process | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1989-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176675-A1 | Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases | ADK, ADORA3, ADORA1 | FDPS 922/4885SMPD1 779/4885GGPS1 492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.